Spondyloarthritis

Early & Long-Term Remission of Spondyloarthritis

July 16, 2021 • By Jason Liebowitz, MD

Cytokine Targets & Treatment Developments for Psoriatic Arthritis & Spondyloarthritis

March 15, 2021 • By Carina Stanton

The Effects of IL-17A Inhibitors on the Microbiota

February 16, 2021 • By Vanessa Caceres

MRI & Axial Spondyloarthritis: Experts Discuss Controversies in the Diagnostic Evaluation of axSpA

January 25, 2021 • By Lara C. Pullen, PhD

PG_Traveler / shutterstock.com

Case Report: Is It Reactive or IBD-Associated Arthritis?

January 19, 2021 • By Hanan Ibrahim, MD, Weixia Guo, MD, & Ayad Alkhatib, MD

FDA Receives Upadacitinib Application for Ankylosing Spondylitis & Approves Tramadol Hydrochloride Oral Solution

September 30, 2020 • By Michele B. Kaufman, PharmD, BCGP

Study Finds Health & Financial Benefits in AxSpA Treat-To-Target Strategy

September 11, 2020 • By Thomas R. Collins

Interleukin 17 Inhibitors Promising in Ankylosing Spondylitis Patients

July 10, 2020 • By Michele B. Kaufman, PharmD, BCGP

Clinical Pearls: What We Know About Nonradiographic Axial Spondyloarthritis

June 16, 2020 • By Jason Liebowitz, MD

Axial Spondyloarthritis & Exercise: Should axSpA Patients Exercise?

March 23, 2020 • By Mike Fillon

1
2
3
…
15
Next Page »